Untreated isolated FTR is associated with excess mortality regardless of gender, comorbidities, #AFib and right ventricular dysfunction! #AHAJournals #ResearchLetter Dreyfus Julien Augustin Coisne Donal Yohann bohbot CHU Amiens-Picardie ahajrnls.org/4aL3L3V

💡Experience an exciting array of Featured Clinical Science in #StructuralHeart Interventions beginning at 2PM! Don't miss out on cutting-edge discoveries unveiled at #NYValves2024! 🫀 Matthew J. Price, MD Amr Abbas Guillaume Bonnet @ppibarot Augustin Coisne Kendra J. Grubb M.D. Vinod Thourani

Another ⭐️LBS presentation #NYValves2024 by Augustin Coisne from #CHOICE registry: 🎯favorable outcomes with #TMVR despite advances #MAC 👍Sebastian Ludwig Juan F. Granada Andrea Scotti Cardiovascular Research Foundation Fabien Praz Univ.-Prof. Dr. Ralph Stephan von Bardeleben #Keepupthefrenchtouch

🌟Some highlights from this afternoon’s Featured Clinical Research session at #NYValves2024!🫀 #CardioTwitter #CardioEd #CardioResearch #CardioX Matthew J. Price, MD Amr Abbas Guillaume Bonnet @ppibarot Augustin Coisne Kendra J. Grubb M.D. Vinod Thourani

🔥 Day 1 of #NYValves2024 was unbelievable! 🥳 So good to be back in NYC, gather with friends, explore cutting/edge science and listen to top world experts! ➡️ Looking forward to day 2! Cardiovascular Research Foundation Tricia Rawh Juan F. Granada Azeem Latib thomas modine Sebastian Ludwig Andrea Scotti

🚨 Exciting findings at #NYValves2024! Triplace by Andrea Scotti 🎯 High AV Block in 15% of patients at 1 month after TTVR; 12.4% new PPM 🎯 Most HAVBs (89%) within 1 week from TTVR 🎯 Baseline LBBB/LAFB/LPFB confers a high risk of HAVB Key points: 🔸 Pre-TTVR risk

Insights on #TMVR in #MTEER 🔴-zone prim #vhdMR anatomies by Sebastian Ludwig at #NYValves2024 🎯superior MR ⬇️ w/ #TMVR (90% </=1+) 🎯similar functional improvement 🎯higher mort w/#TMVR (driven by proc/access) ➡️moving TA to TF access may be 🔑 further improving #TMVR performance

Insights from the TRI-SPA Registry 🇪🇸 at #NYValves! 🎯Residual TR 0/1+ was associated w/ better functional class and less TR recurrence at 1 year. 🎯Less RV remodeling was observed in patients with nonrecurrent TR. 🎯Recurrent TR was associated w/ worse outcomes at 2 years.

We love deadlines😍😍this why we remind you that 📆Thursday 27 June 2024, 12:00 CET (noon) is the your last change to submit your abstract to #EuroEcho2024 👉escardio.org/Congresses-Eve… See you in Berlin! Denisa Muraru Sarah Moharem Elgamal, MBBCh, MSc, PhD👩🏻‍⚕️🫀 EACVI President Vladyslav Kavalerchyk 🇺🇦 #echofirst

💡 Do you think routine postdilation of small BEV might be beneficial in terms of forward-flow hemodynamics after #TAVR? We tried to find an answer Montefiore Heart Azeem Latib Matteo Sturla Cardiovascular Research Foundation Juan F. Granada Manuscript finally out on CCIjournal 🔗 shorturl.at/XmYYJ

Very happy to see our first PRIME-MR manuscript on the prognostic impact of residual MR and mean gradient following #TEER for primary #MR published in JACC Journals! Augustin Coisne Benedikt Koell Daniel Kalbacher thomas modine jörg hausleiter Donal t.ly/UuX8i

🚨 This #JACCINT analysis of the PRIME-MR registry demonstrated the prognostic implication ☠️ of residual MR, not #MVG, in those with primary #MR undergoing #TEER! bit.ly/3xU686U #vhdMR Augustin Coisne

Ne le manquez pas SFC - Valvulopathies , inscrivez-vous ☺️🌟💫

🚀 Elevate Your Echocardiography Skills at ESC Congress in London! 🚀 Join GE Healthcare tutorial room for exclusive training sessions designed to sharpen your expertise in echocardiography. Led by top experts, our sessions offer hands-on experience with the latest tools.

Randomised study for the Optimal Treatment of symptomatic patients with low-gradient severe Aortic valve Stenosis and preserved left ventricular ejection fraction (ROTAS trial) heart.bmj.com/content/early/… Augustin Coisne Philippe Pibarot Lancellotti CHU de Rennes

Second T-TEER randomized trial: Tri-FR! Presented at #ESC2024 #ESCCongress2024 by Donal showing similar TRILUMINATE results: primary 1Yr endpoint driven by QoL but numerically lower mortality and HFH. Longer FU needed. European Society of Cardiology News European Society of Cardiology

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER tctmd.com/news/trifr-tri…

💥If you still have energy after the ESC congress, join the only #PCRtricuspid focus group referral meeting in 🇫🇷 📅 September 6-7th, CHU Rennes, 2 Rue Henri le Guilloux 🌐 Free registration at : pcronline.com/Network/Tricus… #PCRtricuspid PCRonline 🫀 SFC - Valvulopathies Filiale Echo